Short Interest Worth Watching: BIOTRICITY INCORPORATED (OTCMKTS:BTCY)’s Stock Is Sell After More Market Selling

November 28, 2016 - By Adrian Mccoy   ·   0 Comments

Short Interest Worth Watching: BIOTRICITY INCORPORATED (OTCMKTS:BTCY)'s Stock Is Sell After More Market Selling

The stock of BIOTRICITY INCORPORATED (OTCMKTS:BTCY) registered an increase of 14.29% in short interest. BTCY’s total short interest was 3,200 shares in November as published by FINRA. Its up 14.29% from 2,800 shares, reported previously. With 12,100 shares average volume, it will take short sellers 0 days to cover their BTCY’s short positions. The stock last traded at $2.5 per share. It is down 6.00% since October 29, 2016 and is uptrending. It has underperformed by 0.01% the S&P500.

Biotricity Inc is a Canada-based medical technology company. The company has a market cap of $42.83 million. The Firm delivers remote biometric monitoring solutions, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. It currently has negative earnings. It offers bioflux, an Electrocardiogram monitoring system that enables physicians to diagnose cardiovascular diseases or coronary heart diseases, acts as an ambulatory monitor that detects arrhythmias, performs remote mobile cardiac telemetry diagnostic monitoring, and transmits ECG data via a built-in cellular radio in real time.

More notable recent Biotricity Inc (OTCMKTS:BTCY) news were published by: Seekingalpha.com which released: “Biotricity Is A Promising Medical ‘Monitoring As A Service’ Provider” on October 24, 2016, also Globenewswire.com with their article: “biotricity Expands Partnership with the University of Calgary and Expects FDA …” published on September 29, 2016, Globenewswire.com published: “Biometric Monitoring Solutions Provider, Biotricity, Begins Trading on the OTC …” on February 03, 2016. More interesting news about Biotricity Inc (OTCMKTS:BTCY) were released by: Globenewswire.com and their article: “biotricity Finalizes Partnership Expansion with the University of Calgary” published on October 25, 2016 as well as Globenewswire.com‘s news article titled: “biotricity Receives an FDA 510(k) Clearance – Marks Major Milestone in Path to …” with publication date: October 18, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Adrian Mccoy


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>